Abogen Biosciences is an industry-leading clinical-stage biotech company, dedicated to the development of transformative medicines through RNA innovations. Established in 2019, the company has built full-scale in-house capabilities to support the entire mRNA drug development cycle - from protein engineering, mRNA sequence design and synthesis, lipid nanoparticle (LNP) delivery, formulation, and all the way to commercial-scale manufacturing.